Investigators Develop Model to Predict Overall Survival in Adults Diagnosed with Advanced Stage Hodgkin Lymphoma

Investigators from Rutgers Cancer Institute of New Jersey and Tufts Medical Center collaborated to develop and validate the Advanced-stage Hodgkin lymphoma International Prognostication Index (A-HIPI), a state-of-the-art clinical decision model to predict five-year, progression-free and overall survival in adults with advanced-stage classic Hodgkin lymphoma. The work was published in the Journal of Clinical Oncology simultaneously with an oral abstract presentation at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition. Learn more

Rutgers Cancer Institute of New Jersey: A Year in Review

Throughout 2022, Rutgers Cancer Institute of New Jersey, the state’s leading cancer program and only National Cancer Institute–designated Comprehensive Cancer Center, together with RWJBarnabas Health, conducted groundbreaking research, provided innovative clinical trials, expanded its multidisciplinary team of highly specialized and internationally-known cancer experts, and celebrated milestones including a topping off ceremony for the Jack and Sheryl Morris Cancer Center, the state’s first freestanding cancer hospital. We reflect on these advancements and look forward to a fruitful 2023. Click here for a full selection of our milestones and research discoveries this past year.

HPV and Cervical Cancer, Your Questions Answered

Cervical cancer is almost always caused by the human papilloma virus (HPV), which nearly every sexually active person will be exposed to in their lifetime. Some people may feel uncomfortable asking their doctor about sexual health, including topics like cervical cancer and HPV. James K. Aikins, Jr., MD, FACOG, FACS, chief of gynecologic oncology at Rutgers Cancer Institute of New Jersey and associate professor of obstetrics, gynecology and reproductive sciences at Rutgers Robert Wood Johnson Medical School, answers questions about HPV vaccination, Pap tests, cervical cancer prevention and more. Learn more

Help Save Lives during National Blood Donor Month

Chemotherapy, radiation, and other treatments used to treat cancer can impact the body’s ability to generate healthy blood cells, so those undergoing cancer treatment routinely require blood transfusions. Blood donations typically dwindle in the winter months due to busy holiday schedules, inclement weather and seasonal illnesses like the flu. Jacqueline Manago, RN,  BMT coordinator in the Blood and Marrow Transplant and Cellular Therapies Program at Rutgers Cancer Institute of New Jersey, explains how your blood can help cancer patients and how you can safely donate this month. Read more

As New Jersey’s only NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, provides patients access to the most advanced treatment options including complex surgical procedures, sophisticated radiation therapy techniques, innovative clinical trials, immunotherapy, and precision medicine.
Join our Mailing List
Facebook  Twitter  Instagram  Linkedin  Youtube